Drug Type Antitoxin |
Synonyms Anavip, Crotalidae immune F(ab)2 (equine), Crotalidae snake antivenom + [1] |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (06 May 2015), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Crotaline Snake Venom | US | 06 May 2015 | |
Crotaline Snake Venom | US | 06 May 2015 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blood Coagulation Disorders | Phase 2 | US | 01 Jan 2005 |
Phase 2 | 12 | F(ab)2 Antivenom (Anavip Crotalinae (Pit Viper) Equine Immune F(ab)2 Antivenom) | kvcsaetsdm(tigykgsmvl) = pouljyajnh hkqibzdvcw (memvkdnlbd, ghcdiceacf - mtqjdxcfwa) View more | - | 24 Mar 2009 | ||
(CroFab Crotalidae Polyvalent Immune Fab, Ovine Antivenom) | kvcsaetsdm(tigykgsmvl) = egehxxigou hkqibzdvcw (memvkdnlbd, wjhdapjotz - dvcvbpkeqh) View more |